As covered in a story from Venture Beat and from their own press release, Cogentus Pharmaceuticals of Menlo Park, CA just received $62.5 million in third round funding for their combination drug of cl… more →
HIPPOCRATechclementine wrote 2 months ago: This story at the Miami Herald saddens me. It also infuriates me. When are doctors and the FDA going … more →
highboldtage wrote 2 months ago: PHARMA OUTRAGE: 7 YEAR OLD HANGS HIMSELF IN FLORIDA, PRESCRIBED ANTIPSYCHOTICS “OFF LABEL … more →
neighborhoodwatcher wrote 3 months ago: Thank you for clicking this link to find out more. Ever since the new class of antidepressants hit t … more →
abrandemihl wrote 3 months ago: The AP (3/23) reported that on Mar. 23, pharmaceutical developer Eli Lilly & Co. announced that … more →
timeinctemp wrote 3 months ago: MONDAY, March 23 (HealthDay News) — The bipolar depression drug Symbyax (fluoxetine hydrochloride; o … more →
yumers wrote 3 months ago: Symbyax, a combination drug of Zyprexa and Prozac, has been approved today by the FDA for treating t … more →
atorturedsoul wrote 1 year ago: When I started on Symbyax a month ago, it was less than a week when I started feeling like I had fou … more →
KHOI wrote 1 year ago: As covered in a story from Venture Beat and from their own press release, Cogentus Pharmaceuticals o … more →